/PRNewswire/ Israeli biotechnology company, BioGenCell, founded by Dr. Yael Porat and Prof. Michael Belkin, and developer of unique technology for using.
The Israeli startup uses stem cells from the patient’s own blood to treat microvascular diseases and is aiming to develop products that may be usable to restore tissues damaged by diabetes, kidney failure, pulmonary hypertension, heart failure, stroke, blindness, and more